Publication: Life Sciences Capital Fund : Malaysia Case Study
dc.contributor.author | World Bank | |
dc.date.accessioned | 2014-09-12T20:57:43Z | |
dc.date.available | 2014-09-12T20:57:43Z | |
dc.date.issued | 2014 | |
dc.description.abstract | The Malaysian Life Sciences Capital Fund (MLSCF) is a venture capital fund based in Kuala Lumpur, Malaysia. MLSCF has succeeded in transferring biotechnologies from more-developed to less developed countries. The specific technologies of interest to the fund have the potential to significantly improve farm productivity. Two organizations, one public and the other private, co-manage MLSCF. They are the Malaysian Technology Development Corporation (MTDC), a government organization, and Burrill and Company, a San Francisco-based merchant bank. The fund manages $150 million in committed capital. The concept underlying the fund is to pursue science without borders through a process of open innovation. Open innovation greatly reduces the transaction costs of technology transfer. | en |
dc.identifier | http://documents.worldbank.org/curated/en/2014/01/20144204/life-sciences-capital-fund-lscf-malaysia-case-study | |
dc.identifier.doi | 10.1596/20102 | |
dc.identifier.uri | https://hdl.handle.net/10986/20102 | |
dc.language | English | |
dc.language.iso | en_US | |
dc.publisher | Washington, DC | |
dc.rights | CC BY 3.0 IGO | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/igo/ | |
dc.subject | ACCOUNTING | |
dc.subject | ACQUISITION | |
dc.subject | ACQUISITIONS | |
dc.subject | ACTIVE MARKETS | |
dc.subject | BIOTECHNOLOGIES | |
dc.subject | BIOTECHNOLOGY | |
dc.subject | BOARD MEMBERS | |
dc.subject | BOARD MEMBERSHIPS | |
dc.subject | BROKER | |
dc.subject | BUSINESS ENVIRONMENT | |
dc.subject | BUSINESS MODEL | |
dc.subject | BUSINESS OPPORTUNITY | |
dc.subject | BUSINESS PLAN | |
dc.subject | BUSINESS PROCESSES | |
dc.subject | BUSINESS REPUTATION | |
dc.subject | CAPABILITIES | |
dc.subject | CAPITAL FUND | |
dc.subject | CAPITAL FUNDS | |
dc.subject | CAPITAL REQUIREMENTS | |
dc.subject | CEOS | |
dc.subject | CHIEF FINANCIAL OFFICER | |
dc.subject | CHIEF FINANCIAL OFFICERS | |
dc.subject | COLLABORATION | |
dc.subject | COMMERCIAL ACTIVITIES | |
dc.subject | COMMERCIAL BANKS | |
dc.subject | COMMODITY | |
dc.subject | COMPANY | |
dc.subject | COMPETITIVE ADVANTAGE | |
dc.subject | COMPETITIVENESS | |
dc.subject | COPYRIGHT | |
dc.subject | CORPORATION | |
dc.subject | CORPORATIONS | |
dc.subject | CRITICAL SUCCESS FACTORS | |
dc.subject | CULTURAL CHANGE | |
dc.subject | DECISION-MAKING | |
dc.subject | DEVELOPING COUNTRIES | |
dc.subject | DIRECT INVESTMENTS | |
dc.subject | DOMAIN | |
dc.subject | EMERGING MARKETS | |
dc.subject | ENTERPRISE DEVELOPMENT | |
dc.subject | ENTREPRENEUR | |
dc.subject | ENTREPRENEURS | |
dc.subject | EQUITY FUND | |
dc.subject | FINANCIAL SUPPORT | |
dc.subject | FIRMS | |
dc.subject | FOREIGN DIRECT INVESTMENT | |
dc.subject | GENERAL PARTNER | |
dc.subject | GOVERNMENT FUNDING | |
dc.subject | GOVERNMENT ORGANIZATION | |
dc.subject | GROWTH CYCLES | |
dc.subject | IMPACT ASSESSMENT | |
dc.subject | INCORPORATED | |
dc.subject | INDIVIDUAL COMPANY | |
dc.subject | INDUSTRIAL DEVELOPMENT | |
dc.subject | INDUSTRIAL PRODUCTION | |
dc.subject | INNOVATION | |
dc.subject | INNOVATIONS | |
dc.subject | INSTITUTION | |
dc.subject | INSTITUTIONAL FRAMEWORK | |
dc.subject | INTANGIBLE | |
dc.subject | INTELLECTUAL PROPERTY | |
dc.subject | INTELLECTUAL PROPERTY RIGHTS | |
dc.subject | INTERNATIONAL BANK | |
dc.subject | INVESTING | |
dc.subject | INVESTMENT ALTERNATIVES | |
dc.subject | INVESTMENT FUND | |
dc.subject | INVESTMENT INSTITUTION | |
dc.subject | INVESTMENT INSTITUTIONS | |
dc.subject | INVESTMENT OPPORTUNITIES | |
dc.subject | INVESTMENT OPPORTUNITY | |
dc.subject | INVESTMENT PROCESS | |
dc.subject | JOINT VENTURE | |
dc.subject | JOINT VENTURES | |
dc.subject | LICENSE | |
dc.subject | LICENSES | |
dc.subject | LICENSING | |
dc.subject | LIMITED | |
dc.subject | LOCAL BUSINESS | |
dc.subject | LOCAL COMPANIES | |
dc.subject | LOCAL MARKET | |
dc.subject | MANAGEMENT METHODS | |
dc.subject | MARKET ENTRY | |
dc.subject | MARKET OPPORTUNITIES | |
dc.subject | MARKET OPPORTUNITY | |
dc.subject | MATERIAL | |
dc.subject | MATURITY | |
dc.subject | MERCHANT BANK | |
dc.subject | MERGER | |
dc.subject | MERGERS | |
dc.subject | MUTUAL FUNDS | |
dc.subject | NETWORKS | |
dc.subject | NEW TECHNOLOGIES | |
dc.subject | NEW TECHNOLOGY | |
dc.subject | OUTSIDE INVESTORS | |
dc.subject | PHOTO | |
dc.subject | PLEDGES | |
dc.subject | POLITICAL WILL | |
dc.subject | PORTFOLIO | |
dc.subject | PRIVATE INVESTMENT | |
dc.subject | PRIVATE PARTNERSHIP | |
dc.subject | PRIVATE SECTOR | |
dc.subject | PRODUCTION PROCESSES | |
dc.subject | PRODUCTIVITY | |
dc.subject | PROPRIETARY | |
dc.subject | PROTECTION OF INTELLECTUAL PROPERTY | |
dc.subject | PROTOTYPE | |
dc.subject | PUBLIC EXCHANGES | |
dc.subject | QUERIES | |
dc.subject | RESEARCH PROGRAMS | |
dc.subject | RESERVES | |
dc.subject | RESULT | |
dc.subject | RESULTS | |
dc.subject | RETURN | |
dc.subject | RETURNS | |
dc.subject | SCIENTISTS | |
dc.subject | SERVICE PROVIDERS | |
dc.subject | SPECIFIC INVESTMENT | |
dc.subject | STOCK OWNERSHIP | |
dc.subject | STOCKS | |
dc.subject | SUPPLY CHAIN | |
dc.subject | SUPPLY CHAIN INTEGRATION | |
dc.subject | TARGETS | |
dc.subject | TAX | |
dc.subject | TAX INCENTIVES | |
dc.subject | TECHNOLOGY DEVELOPMENT | |
dc.subject | TECHNOLOGY TRANSFER | |
dc.subject | TECHNOLOGY TRANSFERS | |
dc.subject | TELEPHONE | |
dc.subject | TIME-TO-MARKET | |
dc.subject | TRANCHE | |
dc.subject | TRANCHES | |
dc.subject | TRANSACTION | |
dc.subject | TRANSACTION COSTS | |
dc.subject | TRANSLATION | |
dc.subject | TREATY | |
dc.subject | UNIVERSITIES | |
dc.subject | USER | |
dc.subject | USES | |
dc.subject | VALUATION | |
dc.subject | VENTURE CAPITAL | |
dc.subject | WEB | |
dc.subject | WEB SITE | |
dc.subject | WORLD TRADE | |
dc.title | Life Sciences Capital Fund : Malaysia Case Study | en |
dspace.entity.type | Publication | |
okr.date.disclosure | 2014-08-26 | |
okr.date.doiregistration | 2025-05-05T12:46:26.839110Z | |
okr.doctype | Publications & Research::Working Paper | |
okr.doctype | Publications & Research | |
okr.docurl | http://documents.worldbank.org/curated/en/2014/01/20144204/life-sciences-capital-fund-lscf-malaysia-case-study | |
okr.globalpractice | Transport and ICT | |
okr.globalpractice | Finance and Markets | |
okr.globalpractice | Governance | |
okr.globalpractice | Transport and ICT | |
okr.globalpractice | Trade and Competitiveness | |
okr.guid | 604921468088742113 | |
okr.identifier.externaldocumentum | 000333037_20140826142148 | |
okr.identifier.internaldocumentum | 20144204 | |
okr.identifier.report | 90125 | |
okr.language.supported | en | |
okr.pdfurl | http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2014/08/26/000333037_20140826142148/Rendered/PDF/901250WP0Box380siness.malaysia.web0.pdf | en |
okr.region.administrative | East Asia and Pacific | |
okr.region.country | Malaysia | |
okr.topic | Finance and Financial Sector Development::Microfinance | |
okr.topic | Information and Communication Technologies::ICT Policy and Strategies | |
okr.topic | Law and Development::Corporate Law | |
okr.topic | Finance and Financial Sector Development::Debt Markets | |
okr.topic | Private Sector Development::E-Business | |
okr.unit | Agriculture - GP (GAGDR) | |
okr.volume | 1 of 1 |
Files
License bundle
1 - 1 of 1